Report Detail

Pharma & Healthcare Global (United States, European Union and China) Gaucher Disease Treatment Market Research Report 2019-2025

  • RnM3669902
  • |
  • 14 August, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Gaucher Disease Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Type 1 (Neuropathic Forms)
      • 1.3.3 Type 2 (Perinatal Lethal Form)
      • 1.3.4 Type 3 (Slow-neurologic Decay Form)
    • 1.4 Market Segment by Application
      • 1.4.1 Global Gaucher Disease Treatment Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Ambulatory Surgical Centers
      • 1.4.4 Clinical Research Institutes
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Gaucher Disease Treatment Market Size
      • 2.1.1 Global Gaucher Disease Treatment Revenue 2014-2025
      • 2.1.2 Global Gaucher Disease Treatment Sales 2014-2025
    • 2.2 Gaucher Disease Treatment Growth Rate by Regions
      • 2.2.1 Global Gaucher Disease Treatment Sales by Regions 2014-2019
      • 2.2.2 Global Gaucher Disease Treatment Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Gaucher Disease Treatment Sales by Manufacturers
      • 3.1.1 Gaucher Disease Treatment Sales by Manufacturers 2014-2019
      • 3.1.2 Gaucher Disease Treatment Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Gaucher Disease Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Gaucher Disease Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Gaucher Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Gaucher Disease Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Gaucher Disease Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Gaucher Disease Treatment Market
    • 3.6 Key Manufacturers Gaucher Disease Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Type 1 (Neuropathic Forms) Sales and Revenue (2014-2019)
      • 4.1.2 Type 2 (Perinatal Lethal Form) Sales and Revenue (2014-2019)
      • 4.1.3 Type 3 (Slow-neurologic Decay Form) Sales and Revenue (2014-2019)
    • 4.2 Global Gaucher Disease Treatment Sales Market Share by Type
    • 4.3 Global Gaucher Disease Treatment Revenue Market Share by Type
    • 4.4 Gaucher Disease Treatment Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Gaucher Disease Treatment Sales by Application

    6 United States

    • 6.1 United States Gaucher Disease Treatment Breakdown Data by Company
    • 6.2 United States Gaucher Disease Treatment Breakdown Data by Type
    • 6.3 United States Gaucher Disease Treatment Breakdown Data by Application

    7 European Union

    • 7.1 European Union Gaucher Disease Treatment Breakdown Data by Company
    • 7.2 European Union Gaucher Disease Treatment Breakdown Data by Type
    • 7.3 European Union Gaucher Disease Treatment Breakdown Data by Application

    8 China

    • 8.1 China Gaucher Disease Treatment Breakdown Data by Company
    • 8.2 China Gaucher Disease Treatment Breakdown Data by Type
    • 8.3 China Gaucher Disease Treatment Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Gaucher Disease Treatment Breakdown Data by Company
    • 9.2 Rest of World Gaucher Disease Treatment Breakdown Data by Type
    • 9.3 Rest of World Gaucher Disease Treatment Breakdown Data by Application
    • 9.4 Rest of World Gaucher Disease Treatment Breakdown Data by Countries
      • 9.4.1 Rest of World Gaucher Disease Treatment Sales by Countries
      • 9.4.2 Rest of World Gaucher Disease Treatment Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Abbott
      • 10.1.1 Abbott Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.1.4 Gaucher Disease Treatment Product Introduction
      • 10.1.5 Abbott Recent Development
    • 10.2 Aptalis Pharma
      • 10.2.1 Aptalis Pharma Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.2.4 Gaucher Disease Treatment Product Introduction
      • 10.2.5 Aptalis Pharma Recent Development
    • 10.3 Genzyme Corporation
      • 10.3.1 Genzyme Corporation Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.3.4 Gaucher Disease Treatment Product Introduction
      • 10.3.5 Genzyme Corporation Recent Development
    • 10.4 GlaxoSmithKline (GSK)
      • 10.4.1 GlaxoSmithKline (GSK) Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.4.4 Gaucher Disease Treatment Product Introduction
      • 10.4.5 GlaxoSmithKline (GSK) Recent Development
    • 10.5 Pfizer Inc
      • 10.5.1 Pfizer Inc Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.5.4 Gaucher Disease Treatment Product Introduction
      • 10.5.5 Pfizer Inc Recent Development
    • 10.6 Shire Human Genetic Therapies
      • 10.6.1 Shire Human Genetic Therapies Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.6.4 Gaucher Disease Treatment Product Introduction
      • 10.6.5 Shire Human Genetic Therapies Recent Development
    • 10.7 Eli Lilly and Company
      • 10.7.1 Eli Lilly and Company Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.7.4 Gaucher Disease Treatment Product Introduction
      • 10.7.5 Eli Lilly and Company Recent Development
    • 10.8 Enobia Pharma Inc
      • 10.8.1 Enobia Pharma Inc Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.8.4 Gaucher Disease Treatment Product Introduction
      • 10.8.5 Enobia Pharma Inc Recent Development
    • 10.9 Anthera Pharmaceuticals
      • 10.9.1 Anthera Pharmaceuticals Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.9.4 Gaucher Disease Treatment Product Introduction
      • 10.9.5 Anthera Pharmaceuticals Recent Development
    • 10.10 BioMarin Pharmaceutical
      • 10.10.1 BioMarin Pharmaceutical Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Gaucher Disease Treatment
      • 10.10.4 Gaucher Disease Treatment Product Introduction
      • 10.10.5 BioMarin Pharmaceutical Recent Development
    • 10.11 MedPro Rx
    • 10.12 Zymenex A/S

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Gaucher Disease Treatment Sales Channels
      • 11.2.2 Gaucher Disease Treatment Distributors
    • 11.3 Gaucher Disease Treatment Customers

    12 Market Forecast

    • 12.1 Global Gaucher Disease Treatment Sales and Revenue Forecast 2019-2025
    • 12.2 Global Gaucher Disease Treatment Sales Forecast by Type
    • 12.3 Global Gaucher Disease Treatment Sales Forecast by Application
    • 12.4 Gaucher Disease Treatment Forecast by Regions
      • 12.4.1 Global Gaucher Disease Treatment Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Gaucher Disease Treatment Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Gaucher Disease Treatment is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gaucher Disease Treatment.

      This report studies the global market size of Gaucher Disease Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Gaucher Disease Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbott
      Aptalis Pharma
      Genzyme Corporation
      GlaxoSmithKline (GSK)
      Pfizer Inc
      Shire Human Genetic Therapies
      Eli Lilly and Company
      Enobia Pharma Inc
      Anthera Pharmaceuticals
      BioMarin Pharmaceutical
      MedPro Rx
      Zymenex A/S

      Market Segment by Product Type
      Type 1 (Neuropathic Forms)
      Type 2 (Perinatal Lethal Form)
      Type 3 (Slow-neurologic Decay Form)

      Market Segment by Application
      Hospitals
      Ambulatory Surgical Centers
      Clinical Research Institutes

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Gaucher Disease Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Gaucher Disease Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Gaucher Disease Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025


      Summary:
      Get latest Market Research Reports on Gaucher Disease Treatment. Industry analysis & Market Report on Gaucher Disease Treatment is a syndicated market report, published as Global (United States, European Union and China) Gaucher Disease Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Gaucher Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,496.46
      3,744.69
      4,992.92
      2,959.49
      4,439.24
      5,918.98
      356,286.72
      534,430.08
      712,573.44
      233,795.12
      350,692.68
      467,590.24
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report